Zevra Therapeutics, Inc. · NASDAQ:ZVRA
Vanguard Capital Management LLC reported a 5.11% stake in Zevra Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 31, 2026
Vanguard Capital Management LLC reported a 5.11% stake in Zevra Therapeutics, Inc., 3,024,980 shares, as a passive investor on Jun 30, 2026. Filed Jul 31, 2026 (Schedule 13G).
- Stake
- 5.11%
- Shares
- 3,024,980
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Capital Management | 5.11% | 3,024,980 |
Source
Related
- Zevra Therapeutics, Inc.
- Vanguard Capital Management LLC
- Zevra Therapeutics, Inc. shareholders
- Form 4 · McFarlane Neil F. · Oct 13, 2026
- Form 4 · Thompson Rahsaan · Aug 17, 2026
- Schedule 13G/A · Woodline Partners LP · Aug 14, 2026
- Form 4 · Watton Corey Michael · Aug 12, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026